1726-46341726-4634S1726-4634202100010017110.17843/rpmesp.2021.381.6627PerúPeru000120210001202138117117720201510102021301159-6820206111277-81FDA Guidance on Conduct of Clinical Trials of Medical Products during COVID-19 Public Health Emergency2020Organización Panamericana de la Salud2020World Health Organization2017Organización Panamericana de la Salud20202020711Organización Panamericana de la Salud202020202020Organización Panamericana de la Salud202020191-720203733401-2202010844703-5202036033213-52020U.S. Food and Drug Administration2020Agência Nacional de Vigilância Sanitária - AnvisaInstituto Nacional de Salud (Perú)Resolución Ministerial N°339-2020-MINSA20122944431-620203712020370